Mackay Shields LLC Lannett CO Inc Transaction History

Mackay Shields LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 04, 2020	SELL	$4.9 - $7.12 $246,470 - $358,136	-50,300 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$6.43 - $9.86 $18,647 - $28,594	2,900 Added 6.12%	50,300 $365,000
Q1 2020 May 08, 2020	BUY	$6.36 - $10.05 $15,900 - $25,125	2,500 Added 5.57%	47,400 $329,000
Q4 2019 Feb 11, 2020	BUY	$8.49 - $12.81 $242,814 - $366,366	28,600 Added 175.46%	44,900 $396,000
Q3 2019 Nov 01, 2019	BUY	$5.58 - $14.47 $90,954 - $235,861	16,300 New	16,300 $183,000
Q3 2018 Nov 14, 2018	SELL	$4.75 - $14.5 $211,375 - $645,250	-44,500 Closed	0 $0
Q2 2018 Aug 06, 2018	SELL	$13.3 - $17.45 $101,080 - $132,620	-7,600 Reduced 14.59%	44,500 $605,000
Q1 2018 May 03, 2018	BUY	$14.7 - $24.95 $765,870 - $1.3 Million	52,100 New	52,100 $836,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

Stay updated on Mackay Shields LLC with notifications on news.